NUS study shows Artemisinin-ALA co-treatment could destroy cancer cells

A new study conducted by researchers from the National University of Singapore (NUS) has revealed that the co-treatment using artemisinin and aminolaevulinic acid (ALA) can potentially kill cancer cells and suppress tumour growth with fewer side effe …
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news